Enwave Corp ( (TSE:ENW) ) just unveiled an update.
EnWave Corporation has entered into a master service agreement with BioTechnique LLC, a pharmaceutical contract manufacturing service provider, to evaluate EnWave’s Radiant Energy Vacuum (REV™) technology as a potential alternative to lyophilization in the biopharmaceutical industry. The collaboration will involve testing liquid products using EnWave’s pilot-scale REV™ machinery, and if successful, BioTechnique may acquire the technology for its own use, potentially enhancing EnWave’s market presence in the pharmaceutical sector.
More about Enwave Corp
EnWave Corporation is a global leader in vacuum microwave dehydration technology, headquartered in Delta, British Columbia. The company has developed its Radiant Energy Vacuum (REV™) technology, which offers a scalable drying solution for the food, pharmaceutical, and cannabis industries. EnWave partners with over fifty companies across twenty-four countries, providing innovative drying solutions that enhance product quality and efficiency.
YTD Price Performance: 9.09%
Average Trading Volume: 66,628
Technical Sentiment Signal: Buy
Current Market Cap: C$26.66M
See more data about ENW stock on TipRanks’ Stock Analysis page.